Etfs Sp Biotech Etf Ten Year Return
| CURE Etf | 46.80 0.26 0.55% |
ETFS SP Biotech fundamentals help investors to digest information that contributes to ETFS SP's financial success or failures. It also enables traders to predict the movement of ETFS Etf. The fundamental analysis module provides a way to measure ETFS SP's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to ETFS SP etf.
ETFS |
ETFS SP Biotech ETF Ten Year Return Analysis
ETFS SP's Ten Year Return shows the total annualized return generated from holding a fund for the last 10 years and represents fund's capital appreciation, including dividends losses and capital gains distributions. This return indicator is considered by many investors to be the ultimate measures of fund performance and can reflect the overall performance of the market or market segment it invests in.
More About Ten Year Return | All Equity Analysis
Ten Year Return | = | (Mean of Monthly Returns - 1) | X | 100% |
Although Ten Year Fund Return indicator can give a sense of overall fund long-term potential, it is recommended to compare funds performances against other similar funds or market benchmarks for the same 10-year interval.
Based on the latest financial disclosure, ETFS SP Biotech has a Ten Year Return of 0.0%. This indicator is about the same for the average (which is currently at 0.0) family and about the same as Ten Year Return (which currently averages 0.0) category. This indicator is about the same for all Australia etfs average (which is currently at 0.0).
Did you try this?
Run Idea Optimizer Now
Idea OptimizerUse advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |
| All Next | Launch Module |
About ETFS SP Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze ETFS SP Biotech's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of ETFS SP using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of ETFS SP Biotech based on its fundamental data. In general, a quantitative approach, as applied to this etf, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Other Information on Investing in ETFS Etf
ETFS SP financial ratios help investors to determine whether ETFS Etf is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in ETFS with respect to the benefits of owning ETFS SP security.